Our Technology

Accelerating Excellence

Eliminates the need for a tapered version and supports accurate vessel wall apposition2,3

Our Products

Novel Design

CGuardTM EPS combines open-cell flexibility with an ultra-closed-cell micromesh to trap and seal plaque2,3

Our Data

Sustained protection

Safety and stroke prevention efficacy evaluated in large, independent studies with long follow up1,4

Events

03-20-2020 - ICCA Stroke

Frankfurt, Germany – March 20 – 21st, 2020

01-28-2020 - LINC 2020

Leipzig, Germany, January 28, 2020 to Feb 1, 2020

Read more >

Welcome to InspireMD

Solutions that Save Lives. Innovation that Inspires.

InspireMD is dedicated to the development of advanced technologies such as MicroNet®, which aim to transform the future of vascular procedures. Watch Professor Piotr Musialek discuss how CGuardTM could help to improve outcomes in revascularisation.

Watch more expert testimonials.

Learn more about clinical trials with CGuardTM.

 

MGuardTM,  MGuard PrimeTM and CGuardTM are CE Mark approved. They are not approved for sale in the U.S.A.
1. Musialek P et al. PARADIGM-Extend Prospective Academic Trial: Accumulating long-term evidence for MicroNet-covered stent safety and stroke prevention efficacy. Presentation at ESC Congress 2019, Paris, France, 31 August 2019 to 4 September 2019. 2. Wissgott C et al. J Endovasc Ther 2017;24(1):130–137. 3. Musialek P, Hopkins LN, Siddiqui AH. Postepy Kardiol Interwencyjnej 2017;13(2):95–106. 4. Sirignano P et al. J Vasc Surg 2019;70(5S):e163.